IDO1 and ovarian carcinoma: Since IL-6, IL-8, PD-L1, IDO and ROS have been shown to inhibit the killing function of NK cells [25], we treated NK-92 cells with the supernatant of MUC16- treated neutrophils and evaluated the ability of NK-92 to kill ovarian cancer cell line OVCAR-3.